Share this story:

KRx Dental is Quickly Becoming the e-Prescriber for Dental Clinics



KDA GROUP INC.
 

Thetford Mines, Quebec TheNewswire - April 21, 2022 KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) presents an update of its KRx Dental e-prescriber, the only electronic prescriber for dentists developed by its wholly owned subsidiary, Groupe Technologique KDA Inc. ("Tech KDA").

Barely 7 months after its launch, the prescriber software solution for dentists has quickly won over the market. With the signing of important contracts with Progitek, last March, Progident and Novologik, software service providers for dental specialists in Quebec, Tech KDA’s e-prescriber is now being deployed in the majority of dental clinics in Quebec served by these software service providers.

KRx Dental software simplifies prescribing for dentists by putting essential information at their fingertips, so they can prescribe medications professionally, safely and efficiently.

The benefits for dental specialists are multiple:

  • An intelligent e-prescriber integrated directly into the dental management software; 

  • Modules that electronically send their new prescriptions directly to the pharmacy; 

  • Decision trees and algorithms for prescribed drugs to reduce medical risks; 

  • Access to RxVigilance, a leading drug database in Canada; 

  • Access to DSQ (Dossier Santé Québec ) for patient medication history. 

“Our new e-prescription technology platform has been well received, exceeding our expectations. The development strategy of our e-prescriber in the Canadian market is in full swing and the success we are experiencing in Quebec is very encouraging for the growth of this unique product outside of Quebec,” said Marc Lemieux, Chief Executive Officer of KDA.

 

ABOUT KDA GROUP

KDA Group is a leader in technological innovations and specialized solutions in the pharmaceutical market. KDA is a corporation that offers quality products and has a respected expertise among the various stakeholders in the pharmaceutical and medical sectors. Its management team is guided by the vision to pursue leading the way in Canada and internationally. Additional information about the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.

 

- 30 -

 

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

 

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

 

INFORMATION

Marc Lemieux, Chief Executive Officer

514 622-7370

info@groupekda.ca